Cited by 645Cardiac Fibrosis and RemodelingTGF-β signaling in diseasesCongenital heart defects research

IL-11 is a crucial determinant of cardiovascular fibrosis

Open access
Schafer, Sebastian, Viswanathan, Sivakumar, Widjaja, Anissa A., Lim, Wei-Wen, Moreno-Moral, Aida, DeLaughter, Daniel M., Ng, Benjamin, Patone, Giannino +40 more·2017·Nature

Abstract

Fibrosis is a common pathology in cardiovascular disease. In the heart, fibrosis causes mechanical and electrical dysfunction and in the kidney, it predicts the onset of renal failure. Transforming growth factor β1 (TGFβ1) is the principal pro-fibrotic factor, but its inhibition is associated with side effects due to its pleiotropic roles. We hypothesized that downstream effectors of TGFβ1 in fibroblasts could be attractive therapeutic targets and lack upstream toxicity. Here we show, using integrated imaging-genomics analyses of primary human fibroblasts, that upregulation of interleukin-11 (IL-11) is the dominant transcriptional response to TGFβ1 exposure and required for its pro-fibrotic effect. IL-11 and its receptor (IL11RA) are expressed specifically in fibroblasts, in which they drive non-canonical, ERK-dependent autocrine signalling that is required for fibrogenic protein synthesis. In mice, fibroblast-specific Il11 transgene expression or Il-11 injection causes heart and kidney fibrosis and organ failure, whereas genetic deletion of Il11ra1 protects against disease. Therefore, inhibition of IL-11 prevents fibroblast activation across organs and species in response to a range of important pro-fibrotic stimuli. These results reveal a central role of IL-11 in fibrosis and we propose that inhibition of IL-11 is a potential therapeutic strategy to treat fibrotic diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nature24676

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Microbiota-driven intestinal fibrosis may be mediated by induction of the IL-33 receptor ST2 on epithelial cells or by the pro-fibrotic action of TL1A.

    “Microbiota driven intestinal fibrosis may be mediated by induction of the IL-33 receptor ST2 on epithelial cells157 or the pro-fibrotic action of tumor necrosis factor-like cytokine 1A (TL1A)158”

    From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [157]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Schafer, S., Viswanathan, S., Widjaja, A. A., Lim, W.-W., Moreno-Moral, A., DeLaughter, D. M., Ng, B., Patone, G., Chow, K., Khin, E., Tan, J., Chothani, S. P., Ye, L., Rackham, O. J. L., Ko, N. S. J., Sahib, N. E., Pua, C. J., Zhen, N. T. G., Xie, C., Wang, M., Maatz, H., Lim, S., Saar, K., Blachut, S., Petretto, E., Schmidt, S., Putoczki, T., Guimarães-Camboa, N., Wakimoto, H., van Heesch, S., Sigmundsson, K., Lim, S. L., Soon, J. L., Chao, V. T. T., Chua, Y. L., Tan, T. E., Evans, S. M., Loh, Y. J., Jamal, M. H., Ong, K. K., Chua, K. C., Ong, B.-H., Chakaramakkil, M. J., Seidman, J. G., Seidman, C. E., Hubner, N., Sin, K. Y. K., & Cook, S. A.
Affiliations
  • National University of Singapore (SG)
  • National Heart Centre Singapore (SG)
  • Harvard University (US)
  • Max Delbrück Center (DE)
  • The University of Melbourne (AU)
  • KK Women's and Children's Hospital (SG)
  • Brigham and Women's Hospital (US)
Corresponding author
Cook, Stuart A.
Venue
Nature
Published
2017-11-13
Volume
552
Issue
7683
Pages
110-115
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2770331207
Cited by
639
References
42
Citations by year
2026: 75 · 2025: 74 · 2024: 79 · 2023: 81 · 2022: 87 · 2021: 81 · 2020: 80 · 2019: 50 · 2018: 28 · 2017: 3
FWCI
33.92
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (acceptedVersion)
  • National University of Singapore (submittedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
  • ePrints Soton (University of Southampton) (submittedVersion)
  • Spiral (Imperial College London) (submittedVersion)
Funders
  • National Institutes of Health (DP1OD006428)
  • National Heart, Lung, and Blood Institute (R01HL070867, DP1HL117649, R01HL080494)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
Keywords
interleukin-11, IL-11 receptor, myocardial fibrosis, renal fibrosis, TGF-β1, fibroblast activation, ERK signaling, autocrine signaling, fibrotic diseases, therapeutic target, organ failure, renal failure, heart failure
MeSH terms
Animals, Cardiovascular System, Cells, Cultured, Female, Fibroblasts, Fibrosis, Heart, Humans, Kidney, Male, Middle Aged, Myocardium, Protein Biosynthesis, Interleukin-11, Mice, Knockout, Transgenes, Autocrine Communication, Mice, Interleukin-11 Receptor alpha Subunit, Transforming Growth Factor beta1, Organ Dysfunction Scores

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review